SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk.
Saved in:
| Title: | SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk. |
|---|---|
| Authors: | López Moreno SF; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA.; Escuela de Medicina y Ciencias de la Salud, Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey 64710, Nuevo León, Mexico., Lenz SA; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA.; Escuela de Medicina y Ciencias de la Salud, Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey 64710, Nuevo León, Mexico., Casso-Chapa B; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA.; Escuela de Medicina y Ciencias de la Salud, Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey 64710, Nuevo León, Mexico., Paniagua-Bojorges A; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA.; Escuela de Medicina y Ciencias de la Salud, Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey 64710, Nuevo León, Mexico., Kim JH; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA.; Escuela de Medicina y Ciencias de la Salud, Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey 64710, Nuevo León, Mexico., Palaskas NL; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA., Nead KT; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Samanthapudi VSK; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA., Mejia G; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA., Hoang O; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA., Lee J; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA.; Department of Pediatric Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lin SH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Herrmann J; Cardio Oncology Clinic, Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA., Wang G; Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX 77030, USA., Yusuf SW; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA., Iliescu CA; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA., Beinart NI; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA., Manisty C; Institute of Cardiovascular Science, University College London, London WC1E 6BT, UK.; Cardio-Oncology Department, Barts Heart Centre, Barts Health NHS Trust, London EC1A 7BE, UK., Ushio-Fukai M; Department of Medicine, Cardiology, Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA., Fukai T; Department of Medicine, Cardiology, Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA., Ameri P; Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy., Nurieva RI; Department of Immunology, Division of Discovery Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hildebrandt MAT; Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Schadler K; Department of Pediatric Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Koutroumpakis E; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA., Kotla S; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA., Le NT; Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX 77030, USA., Abe JI; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1057, Houston, TX 77030, USA. |
| Source: | Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2025 Nov 21; Vol. 14 (12). Date of Electronic Publication: 2025 Nov 21. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101668981 Publication Model: Electronic Cited Medium: Print ISSN: 2076-3921 (Print) Linking ISSN: 20763921 NLM ISO Abbreviation: Antioxidants (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
